login
login

Europe Daily Bulletin No. 12676

12 March 2021
Contents Publication in full By article 1 / 44
EU RESPONSE TO COVID-19
HEALTH: European Commission authorises Johnson & Johnson vaccine
Brussels, 11/03/2021 (Agence Europe)

Following a positive opinion from the European Medicines Agency, the European Commission authorised a fourth Covid-19 vaccine on Thursday 11 March. This is the viral vector vaccine developed by Johnson & Johnson, the first to only require one injection. 

In giving its opinion, the European Medicines Agency (EMA) examined the results of a clinical study conducted on 44,000 people, which concluded that the vaccine was 67% effective among symptomatic cases. It felt that the benefits...

Contents

EU RESPONSE TO COVID-19
EUROPEAN PARLIAMENT PLENARY
INSTITUTIONAL
SECTORAL POLICIES
ECONOMY - FINANCE
EXTERNAL ACTION
COURT OF JUSTICE OF THE EU
NEWS BRIEFS